Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Cell and Tissue Research|February 4, 2018
Correction to: Epigenetic regulation of neuroblastoma developmentKaat Durinck, Frank SpelemanCell and Tissue Research|January 20, 2018
Epigenetic regulation of neuroblastoma developmentKaat Durinck, Frank SpelemanJournal of Hematology & Oncology|March 9, 2017
T-ALL and thymocytes: a message of noncoding RNAsAnnelynn Wallaert, Kaat Durinck, Tom Taghon, et al.Current Opinion in Hematology|April 26, 2017
Long non-coding RNAs in leukemia: biology and clinical impactTim Lammens, Kaat Durinck, Annelynn Wallaert, et al.Oncotarget|January 2, 2018
Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptomeShana Claeys, Geertrui Denecker, Robrecht Cannoodt, et al.Plos One|January 5, 2024
HTSplotter: An end-to-end data processing, analysis and visualisation tool for chemical and genetic in vitro perturbation screeningCarolina Nunes, Jasper Anckaert, Fanny De Vloed, et al.Nucleic Acids Research|October 18, 2014
A nanobody modulates the p53 transcriptional program without perturbing its functional architectureJonas Bethuyne, Steven De Gieter, Olivier Zwaenepoel, et al.BMC Genomics|March 22, 2019
Purification of high-quality RNA from a small number of fluorescence activated cell sorted zebrafish cells for RNA sequencing purposesSiebe Loontiens, Lisa Depestel, Suzanne Vanhauwaert, et al.Journal of Personalized Medicine|December 24, 2021
From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk NeuroblastomaBieke Decaesteker, Kaat Durinck, Nadine Van Roy, et al.Scientific Reports|December 4, 2018
In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumorsSuzanne Vanhauwaert, Bieke Decaesteker, Sara De Brouwer, et al.Pageof 4